Abstract
Despite great efforts in stroke research, disability and recurrence rates in ischaemic stroke remain unacceptably high. To address this issue, one potential target for novel therapeutics is the glycoprotein von Willebrand factor (vWF), which increases in thrombogenicity especially under high shear rates as it bridges between vascular sub-endothelial collagen and platelets. The rationale for vWF as a potential target in stroke comes from four bodies of evidence. (1) Animal models which recapitulate the pathogenesis of stroke and validate the concept of targeting vWF for stroke prevention and the use of the vWF cleavage enzyme ADAMTS13 in acute stroke treatment. (2) Extensive epidemiologic data establishing the prognostic role of vWF in the clinical setting showing that high vWF levels are associated with an increased risk of first stroke, stroke recurrence or stroke-associated mortality. As such, vWF levels may be a suitable marker for further risk stratification to potentially fine-tune current risk prediction models which are mainly based on clinical and imaging data. (3) Genetic studies showing an association between vWF levels and stroke risk on genomic levels. Finally, (4) studies of patients with primary disorders of exces...Continue Reading
Citations
Nov 7, 2019·Journal of Neurointerventional Surgery·Andrew DouglasKaren Doyle
Jul 18, 2020·Thrombosis and Haemostasis·Katarina D KovacevicJolanta M Siller-Matula
Oct 26, 2018·Stroke; a Journal of Cerebral Circulation·Titilope A FasipeSean P Marrelli
Feb 6, 2020·Journal of Thrombosis and Haemostasis : JTH·Shuhao ZhuBernd Jilma
Jul 9, 2020·Scientific Reports·Katarina D KovacevicBernd Jilma
Apr 11, 2020·Journal of Thrombosis and Haemostasis : JTH·Shuhao ZhuBernd Jilma
Jul 28, 2020·International Journal of Molecular Sciences·Corlia GroblerEtheresia Pretorius
Feb 6, 2021·Scientific Reports·Katarina D KovacevicBernd Jilma
Dec 22, 2020·Frontiers in Immunology·Junxian YangJiangguo Lin
Dec 12, 2020·Acta Pharmacologica Sinica·Cheng-di LiuGuan-Hua Du
Jan 29, 2021·Thrombosis and Haemostasis·Ferdows AtiqFrank W G Leebeek
Mar 7, 2021·Biology·Leoné MalanNico T Malan
May 18, 2021·Frontiers in Immunology·Antonela LelasDrazen Pulanic
Jun 15, 2021·Frontiers in Neurology·Saiyet de la C BaezPedro Valdes-Sosa
Nov 4, 2020·Life Sciences·Jun WangXia Li
Oct 9, 2021·Scientific Reports·Hiromasa HiraiNahoko Ogata